Haematology

News

Sobi sizes up $1.7bn merger with blood cancer biotech CTI

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibro

News

Leaked data shows stellar efficacy for J&J’s Carvykti

Johnson & Johnson was preparing to divulge the data from its eagerly-awaited CARTITUDE-4 trial of CAR-T therapy Carvykti later this year, but a leak of the data has gi

News

FDA clears Gamida’s cord blood therapy for cancer patients

The FDA has approved a stem cell-based therapy for cancer patients from Israeli biotech Gamida Cell that is designed to help them recover more quickly from aggressive chem

News

Despite FDA doubts, advisors back first-line Polivy use

Panel votes 11 to 2 to back Roche's drug for treatment-naïve diffuse large B-cell lymphoma.

News

Hemab raises $135m for rare bleeding disorder trials

Cash will be used to advance drugs for Glanzmann thrombasthenia and von Willebrand disease.

News

Takeda claims first phase 3 win in rare disease cTTP

Takeda has reported positive results from a phase 3 trial of its experimental therapy TAK-755 for ultra-rare disease congenital thrombotic thrombocytopenic purpura (cTTP), setting up regula

Sobi sizes up $1.7bn merger with blood cancer biotech CTI

Leaked data shows stellar efficacy for J&J’s Carvykti

FDA clears Gamida’s cord blood therapy for cancer patients

Despite FDA doubts, advisors back first-line Polivy use

Hemab raises $135m for rare bleeding disorder trials

Takeda claims first phase 3 win in rare disease cTTP

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Haematology

Editor's Picks